Fresenius | FRE - Current Assets


Fresenius reported EUR11.03B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Akzo Nobel EUR 8.12B 594M Jun/2026
Alcon AG USD 6.62B 171M Mar/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
BASF EUR 38.79B 1.18B Jun/2026
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
DaVita Healthcare Partners USD 4.19B 126.96M Jun/2026
Demant DKK 10.08B 128M Dec/2025
E.ON EUR 28.03B 5.75B Mar/2026
Essilor EUR 11.24B 770M Jun/2026
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Getinge SEK 15.77B 2.39B Jun/2026
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.56B 202M Jun/2026
GN Store Nord DKK 4.85B 3.79B Mar/2026
GRIFOLS EUR 5.31B 51M Jun/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Novartis USD 27.35B 744M Jun/2026
Philips EUR 9.33B 454M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
RWE EUR 45.61B 11.27B Mar/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Smith & Nephew USD 4.39B 240M Jun/2026